Italia markets closed

ChemoMetec A/S (0DZ0.L)

LSE - LSE Prezzo differito. Valuta in DKK.
Aggiungi a watchlist
820,00+41,50 (+5,33%)
Alla chiusura: 04:53PM GMT
Schermo intero
Chiusura precedente778,50
Denaro0,00 x 0
Lettera0,00 x 0
Min-Max giorno791,00 - 810,50
Intervallo di 52 settimane791,00 - 810,50
Media VolumeN/D
Beta (5 anni mensile)1,59
Rapporto PE (ttm)1,09
EPS (ttm)7,55
Prossima data utiliN/D
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Q1 2022/23 - Good start to the fiscal year with 34% revenue growth

    ANNOUNCEMENT NO. 232 Trading statement for Q1 2022/23 (1 July - 30 September 2022) Good start to the fiscal year with 34% revenue growth The financial year 2022/23 is off to a good start with revenue up 34% in the first quarter to DKK 113.8 million from DKK 85.0 million in the year-earlier period. While all product segments recorded growth, the North American market remains the main geographical growth driver. EBITDA amounted to DKK 65.2 million, a year-on-year increase of 50%, for an EBITDA mar

  • GlobeNewswire

    Annual Report 2021/22 - Strong growth despite challenging conditions

    ANNOUNCEMENT NO. 229 15 September 2022 Annual Report 2021/22 (1 July 2021 - 30 June 2022) Strong growth despite challenging conditions ChemoMetec grew its revenue by 52% in 2021/22 from DKK 281.1 million to DKK 427.2 million despite the extraordinary market conditions caused by Covid-19 and the war in Ukraine, including supply chain shortages. As a result, EBITDA grew from DKK 135.6 million to DKK 222.9 million, a 64% increase. As in previous years, growth was primarily driven by increasing sale

  • GlobeNewswire

    ChemoMetec-aktien rykker til Large Cap

    PRESSEMEDDELELSE 29. december 2021 ChemoMetec-aktien rykker til Large Cap Fra og med den 3. januar 2022 rykker ChemoMetec-aktien fra Mid Cap til Large Cap-segmentet på Nasdaq Copenhagen. Large Cap-segmentet består af virksomheder, hvis markedsværdi overstiger 1 mia. euro. ChemoMetecs markedsværdi udgør i dag ca. 14 mia. kr. ChemoMetec ser frem til at være en del af Large Cap-segmentet, og ser det som en kvittering for, at såvel vores strategi og daglige arbejde skaber værdi for vores aktionærer.